Forgot your password?

Forgot your username?

database > company
I-Flow Corporation
Medical Devices & Tech
20202 Windrow Drive
Lake Forest, CA 92630 USA
Click for website
Research Sector Medical Devices & Tech
Summary Description
Ambulatory drug delivery systems for pain management and intravenous infusion therapy.
Click here for Financial Data
ambulatory drug delivery, pain, pain management, infusion therapy, anesthetics, anesthesia, chemotherapies, antibiotics, diagnostic agents, nutritional supplements, oncology, cancer, orthopedics, urology , PainManagement, DrugDelivery


I-Flow develops and markets ambulatory drug delivery systems for pain management and intravenous infusion therapy. The company focuses on three distinct markets: Regional Anesthesia, IV Infusion Thera......view more

Products / Services

I-Flow manufactures a line of compact, portable infusion pumps, catheters, needles and pain kits that administer medication directly to the wound site, as well as administer local anesthetics, chemoth......view more

Technology / Differentiation

The ON-Q PainBuster Post-Op Pain Relief System provides continuous infusion of a local anesthetic directly into the patient's surgical site for effective, non-narcotic post-operative pain relief for u...view more

Market / Customers

The annual U.S. post-surgery pain relief market is estimated at $2 billion. This market is about 4% penetrated by narcotic-free regional anethesia therapies. I-Flow estimates that 15 million U.S. surg......view more

Competitors / Substitutes / Alternatives

Narcotics remain I-Flow's chief competitor in the relief of post-surgical pain. About 96% of U.S. patients are treated with narcotics for post-operative pain. Other companies with narcotic-free therap...view more


I-Flow is focused on building market awareness of the clinical and economic advantages of ON-Q technology through a combination of clinical studies, sales force expansion and marketing programs....view more

Analyst Coverage

First Albany Corp., Lazard Freres & Co., Jefferies & Co., Piper Jaffray, Roth Capital Partners, SG Cowen & Co., Sidoti & Company; WR Hambrecht; B. Riley...view more